Gilead Sciences Aktie
WKN: 885823 / ISIN: US3755581036
07.08.2025 23:34:20
|
Gilead Sciences Inc. Q2 Profit Increases, Beats Estimates
(RTTNews) - Gilead Sciences Inc. (GILD) announced earnings for its second quarter that Increased from the same period last year and beat the Street estimates.
The company's earnings came in at $1.960 billion, or $1.56 per share. This compares with $1.614 billion, or $1.29 per share, last year.
Excluding items, Gilead Sciences Inc. reported adjusted earnings of $2.01 per share for the period.
Analysts on average had expected the company to earn $1.96 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 1.8% to $7.082 billion from $6.954 billion last year.
Gilead Sciences Inc. earnings at a glance (GAAP) :
-Earnings: $1.960 Bln. vs. $1.614 Bln. last year. -EPS: $1.56 vs. $1.29 last year. -Revenue: $7.082 Bln vs. $6.954 Bln last year.
-Guidance: Full year EPS guidance: $7.95 - $8.25 Full year revenue guidance: $28.30 - $28.70 Bln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Gilead Sciences Inc.mehr Nachrichten
Analysen zu Gilead Sciences Inc.mehr Analysen
Aktien in diesem Artikel
Gilead Sciences Inc. | 97,37 | 1,35% |
|